Bipartisanship hasn’t exactly been the watchword in Washington over the past month as the new Trump administration grapples with stalled nominations, court battles over its travel ban, and investigations of campaign contacts with Russia.
But deeply divided politicians may still find... Read more »
Here are some notable recent deals made by Boston-area tech companies:
—Burlington, MA-based Nuance Communications (NASDAQ: NUAN) has acquired mCarbon, a Noida, India-based provider of telecommunications products and services, for an estimated $36 million in cash and stock, according to... Read more »
News may be coming out of Washington, DC, at a breakneck pace, but concrete plans regarding the future of the nation’s healthcare system, the FDA, and the pharmaceutical industry have been much slower to materialize. The consternation about President Donald Trump’s... Read more »
You can learn a lot from a quick breakfast meeting. I’m at a French bakery in Assembly Row in Somerville, MA, with executives from Tasktop Technologies, a software company Xconomy has covered for years. Inside, the smell of croissants... Read more »
Rhythm, a Boston biotech developing drugs for rare, life-threatening metabolic disorders, has raised $41 million from a group of crossover investors, a signal that an initial public offering could be on the way.
Rhythm plans to use the new funding... Read more »
Amazon’s voice-enabled smart speakers can order a pizza, play your favorite song on command, set timers, and do plenty of other ordinary tasks. Now, Boston startup Mylestone aims to help make Alexa your personal memory bank.
The company has created a... Read more »
Eight days after Fuze announced a $104 million funding round, the Boston-area communications software firm has replaced its founding CEO.
Steve Kokinos, who co-founded Fuze in 2005, will now serve as executive chairman. The company has appointed Colin Doherty as... Read more »
Perhaps this year, Spark Therapeutics could be the first ever in the U.S. to win approval of a gene therapy with its one-time treatment for an inherited form of blindness. But an approval could also throw Spark into the line of... Read more »
The U.S. Patent and Trademark Office has made a decision in the patent fight over ownership of the landmark CRISPR-Cas9 gene editing technology. The ruling is in favor of the Broad Institute of MIT and Harvard, whose 2014 patents were challenged... Read more »
The final numbers on 2016 fintech funding deals are in from New York-based research firm and investment database CB Insights, and venture capitalists seem to be cooling on the industry.
According to a report released today, financial technology companies around the... Read more »
Another Alzheimer’s drug has failed a major test. Merck (NYSE: MRK) reported late Tuesday that its pill verubecestat was not helping people with significant Alzheimer’s symptoms. The drug maker announced that it halted its EPOCH study early because an oversight group... Read more »
[Updated 2/14/17, 1:07 pm. See below.] Women’s health company Hologic has been looking for ways to enter the fast-growing medical aesthetics market, and the company has now found a way in with a deal to acquire Cynosure for $1.44... Read more »
In three years, investment has jumped more than twenty-fold in startups developing medicines that change the interactions between our bodies and the bacteria that colonize it, known collectively as the human microbiome.
But as a panel of industry insiders noted yesterday... Read more »